Skip to content

Jazz Pharmaceuticals JAZZ Europe — Revenue from Contract with Customer, Excluding Assessed Tax

Other geography segments

All other
$16.7M+2.5%

Similar metrics at other companies

Exelixis logo
EXELEurope — Total revenues
$39.57M+21.0%
Mettler-Toledo International, Inc. logo
MTDEurope — Revenue from Contract with Customer, Excluding Assessed Tax
$278.69M+12.4%
Incyte logo
INCYEurope — Total revenues
$92.43M+34.7%
RPM International logo
RPMEurope — Revenue
$269.39M+20.1%
MKS Instruments logo
MKSIEurope — Revenue
$63M+3.3%
Global Payments logo
GPNEurope — Revenue
$164.95M+4.7%

Other financials

Income statement

See full
Revenue$1.1B+19.1%
Operating income$336.6M+702%
Net income$293.1M+417%
EPS (diluted)$4.43+391%

Balance sheet

See full
Cash & equivalents$667.5M-64.1%
Total debt$5.4B-0.1%
Total equity$4.5B+8.6%
Total assets$11.9B+2.8%

Cash flow

See full
Operating cash flow$408.2M-5.0%
CapEx$19.7M+41.7%
Free cash flow$388.5M-6.6%

Valuation

See full
Market cap$14.11B+54.4%
Enterprise value$18.85B+47.7%
P/S3.2×+0.9×

Profitability

See full
Operating margin-11.9%-28.1pp
Net margin-8.9%-20.5pp
FCF margin28.6%-8.6pp

Returns & leverage

See full
Return on equity-9.1%-21.2pp
Debt / equity1.2×-0.1×
Current ratio-1.3×

Where this comes from

Reported directly by Jazz Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Jazz Pharmaceuticals's europe — revenue from contract with customer, excluding assessed tax.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Jazz Pharmaceuticals's europe — revenue from contract with customer, excluding assessed tax?
Jazz Pharmaceuticals (JAZZ) reported europe — revenue from contract with customer, excluding assessed tax of $92.4M in Q1 2026.
How has Jazz Pharmaceuticals's europe — revenue from contract with customer, excluding assessed tax changed year-over-year?
Jazz Pharmaceuticals's europe — revenue from contract with customer, excluding assessed tax increased by 10.5% year-over-year, from $83.6M to $92.4M.
What is the long-term trend for Jazz Pharmaceuticals's europe — revenue from contract with customer, excluding assessed tax?
Over 4 years (2021 to 2025), Jazz Pharmaceuticals's europe — revenue from contract with customer, excluding assessed tax has grown at a 10.3% compound annual growth rate (CAGR), from $230.85M to $341.68M.
What does europe — revenue from contract with customer, excluding assessed tax mean?
The total net sales revenue generated by the company's operations within the European market.
How do you interpret europe — revenue from contract with customer, excluding assessed tax?
An increase indicates successful product launches, expanded market access, or growing demand for the company's therapeutic offerings in Europe, while a decrease may signal competitive pressure, pricing headwinds, or regulatory challenges in the region.
How does europe — revenue from contract with customer, excluding assessed tax compare across companies?
This is comparable to regional net sales reporting found in the geographic segment disclosures of other multinational biopharmaceutical companies, often categorized as 'International' or 'EMEA' revenue.